Latest

​全球制药公司与 AGC Biologics 敲定双基地协议,交易额超 5 亿欧元

Friday, 06 Nov 2026 3:38PM

该协议基于客户此前针对横滨新工厂、涵盖五个商业化生物制品项目的长期å...

See More
2026 年 Gartner® Magic Quadrant™ for Data Integration Tools 报告发布,Denodo 七度蝉联“领导者”称号

Friday, 06 Nov 2026 3:16PM

Denodo 表示,公司能获得这一殊荣,得益于其强大的智能体 AI 能力以及稳定ä¸...

See More

Other Press Release

AM Best to Present and Participate at 2026 Shanghai International Reinsurance Conference

Friday, 23 Oct 2026 10:07AM

HONG KONG, Oct 23 (Bernama-BUSINESS WIRE) -- Members of AM Best’s analytic team...

See More
New TOURISE and LIONS Advisory Study Reveals How Creativity Creates a Commercial Advantage for Destination Growth

Friday, 23 Oct 2026 9:57AM

 New TOURISE and LIONS Advisory Study Reveals How Creativity Creates a Commercial Advantage for...

See More
Antalpha Increases Investment in Aurelion with US$2 Million Share Subscription

Friday, 23 Oct 2026 9:05AM

SINGAPORE, Oct 23 (Bernama-GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) (&quo...

See More
Antalpha Increases Investment in Aurelion with US$2 Million Share Subscription

Friday, 23 Oct 2026 9:05AM

SINGAPORE, Oct 23 (Bernama-GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) (&quo...

See More
Antalpha Increases Investment in Aurelion with US$2 Million Share Subscription

Friday, 23 Oct 2026 9:05AM

SINGAPORE, Oct 23 (Bernama-GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) (&quo...

See More
Antalpha Increases Investment in Aurelion with US$2 Million Share Subscription

Friday, 23 Oct 2026 9:05AM

SINGAPORE, Oct 23 (Bernama-GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) (&quo...

See More
Antalpha Increases Investment in Aurelion with US$2 Million Share Subscription

Friday, 23 Oct 2026 9:05AM

SINGAPORE, Oct 23 (Bernama-GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) (&quo...

See More
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development

Friday, 23 Oct 2026 9:02AM

Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies ...

See More